Michael Insel

NPI 1164798161ActiveIndividual· Internal Medicine, Critical Care Medicine· Tucson, AZ

Internal Medicine, Critical Care Medicine in Tucson, Arizona, trained at University of Rochester School of Medicine and Dentistry (class of 2012). Their prescriptions cost Medicare Part D more than their services did: $1,811,888 for 948 claims, against $58,165 paid for services in 2024. Actelion Pharmaceuticals US, Inc. reported $18.87 in payments in 2025, mostly food and beverage.

Overview

NPI	1164798161
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Mar 24, 2012
Last updated in NPPES	Dec 27, 2019
Certified by provider	Dec 27, 2019

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Critical Care Medicine Primary	207RC0200X	58706	AZ
Internal Medicine, Pulmonary Disease	207RP1001X	58706	AZ

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (AZ)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	505
Services billed	1,247 across 37 procedure codes
Paid by Medicare	$58,165

Part D prescriptions in 2024

Prescriptions (claims)	948 · 1,358 30-day fills
Patients	137
Total drug cost	$1,811,888
Generic share	46% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Rochester School of Medicine and Dentistry
Graduation year	2012
Medicare specialty	Pulmonary Disease
Telehealth	Offers telehealth